# Monitoring Serum Lactate in Critically Ill Veterinary Patients ## Key Takeaways - Serial lactate measurement is a dynamic indicator of tissue perfusion, crucial for assessing response to resuscitation in critically ill dogs and cats. Elevated lactate most commonly signals anaerobic glycolysis due to tissue hypoxia, but can also result from increased adrenergic drive, impaired hepatic/renal clearance, or mitochondrial dysfunction. - Lactate clearance, calculated as the percentage decrease from the initial value, is a more informative metric than single lactate concentrations. A target of at least 10% clearance per hour during the initial 6 hours of resuscitation is recommended, with normalization (typically < 2 mmol/L) aimed for within 12-24 hours. - Persistent hyperlactatemia despite normalized traditional perfusion parameters (heart rate, blood pressure) indicates occult hypoperfusion and necessitates further investigation or escalation of therapy. Combined assessment with parameters like central venous oxygen saturation (ScvO2) is vital. - Species-specific considerations are critical; feline lactate concentrations may be lower in shock states, and stress or metabolic diseases can cause non-hypoxic hyperlactatemia, making lactate less reliable as a sole indicator of perfusion in cats. - Consistent sampling site (arterial preferred, venous acceptable) and analytical method are paramount for accurate serial trend interpretation. In vitro glycolysis can falsely elevate lactate if samples are not processed promptly. - Lactate monitoring should continue until normalization or plateauing for at least 12 hours in a stable patient. Discontinuation requires a lactate within reference intervals, stable perfusion, and no ongoing lactate production source. --- Serial lactate measurement has become a standard component of resuscitation monitoring in veterinary critical care. This article addresses how practicing veterinarians can use lactate trends to assess tissue perfusion, guide therapeutic decisions, and evaluate response to treatment in dogs and cats with shock or sepsis. The focus is on serial measurement and clearance, not initial diagnosis or single-point interpretation. The content assumes familiarity with shock pathophysiology, fluid therapy principles, and basic acid-base interpretation. Lactate is produced continuously under aerobic conditions, with plasma concentrations reflecting the balance between cellular production and hepatic and renal clearance. In critical illness, hyperlactatemia most often signals anaerobic glycolysis from tissue hypoxia, though other mechanisms including increased adrenergic drive, impaired clearance, and mitochondrial dysfunction contribute. Serial measurement transforms a static laboratory value into a dynamic indicator of perfusion status, allowing clinicians to detect occult hypoperfusion that physical examination and blood pressure may miss. In a clinical observational trial of dogs resuscitated from shock to normal traditional perfusion parameters, decreased central venous oxygen saturation persisted in 37.8% of patients, and hyperlactatemia was commonly recorded, demonstrating that normalization of heart rate and blood pressure does not guarantee restoration of tissue perfusion. Monitoring physiologic parameters such as lactate concentration is useful to detect occult derangements including tissue hypoxia and to determine the effects of therapy, as described in reviews of critical care monitoring. ## At a Glance | Parameter | Clinical Question | Interpretation Guidance | |---|---|---| | Initial lactate | Is hypoperfusion present? | Elevated values support shock, trend matters more than any single value | | Lactate at 2 to 4 hours | Is perfusion improving? | Decreasing values suggest adequate resuscitation | | Lactate clearance | What is the trajectory? | Calculate percentage change from initial value | | Lactate normalization | When can resuscitation be de-escalated? | Normalization supports reduced monitoring intensity | | Persistent hyperlactatemia | Is there ongoing hypoperfusion or another cause? | Reassess perfusion, consider clearance failure, ischemia, or mitochondrial dysfunction | | Rising lactate | Is the patient deteriorating? | Escalate therapy, search for new or ongoing insult | | Lactate with ScvO2 | Is oxygen delivery adequate? | Combined assessment identifies occult hypoperfusion | | Sampling site | Is the trend comparable? | Use consistent sampling site and method | ## Physiology of Lactate Production and Clearance Lactate is the end product of anaerobic glycolysis, generated when pyruvate cannot enter the citric acid cycle. Under hypoxic conditions, the electron transport chain cannot accept reducing equivalents, and pyruvate is reduced to lactate to regenerate NAD+ for continued glycolysis. This pathway produces only 2 ATP per glucose molecule compared with 36 to 38 ATP under aerobic conditions, so tissues with high metabolic demand become lactate generators when oxygen delivery falls. The liver clears roughly 60 to 70% of circulating lactate through gluconeogenesis and oxidation, with the kidneys contributing substantially during hyperlactatemia. Clearance capacity is large but not infinite. Hepatic dysfunction, reduced hepatic blood flow, and impaired renal function all slow lactate elimination and can elevate plasma lactate independent of ongoing tissue hypoxia. This distinction matters clinically: a falling lactate usually indicates improved perfusion, but a static or rising lactate may reflect either persistent hypoperfusion or failure of clearance mechanisms. ## Mechanisms of Hyperlactatemia in Critical Illness ### Type A: Tissue Hypoxia Type A hyperlactatemia results from inadequate oxygen delivery relative to demand. Causes include hypovolemic shock, cardiogenic shock, severe anemia, and hypoxemia. In sepsis, distributive shock produces regional hypoperfusion that may persist despite global hemodynamic normalization. This is the mechanism most relevant to resuscitation monitoring, because lactate trends track the adequacy of oxygen delivery. ### Type B: Non-Hypoxic Causes Type B hyperlactatemia occurs without tissue hypoxia. Sepsis itself can increase lactate through enhanced aerobic glycolysis driven by catecholamines and inflammatory mediators. Mitochondrial dysfunction in septic cells impairs pyruvate utilization even when oxygen is present. Hepatic clearance failure, thiamine deficiency, and certain drugs contribute. In practice, most critically ill patients have mixed mechanisms, and the distinction guides interpretation instead of treatment. ## Lactate as a Perfusion Biomarker Lactate is an indirect marker of microcirculatory function. Direct microcirculatory assessment remains largely investigational, diffuse correlation spectroscopy has shown promise in experimental hypovolemic shock models for real-time monitoring of microvascular blood flow, but this technology is not yet widely available in veterinary practice. Serum lactate therefore serves as the most practical accessible indicator of the balance between oxygen delivery and consumption. The relationship between lactate and perfusion is not linear. Lactate rises when oxygen delivery falls below a critical threshold, but the response is delayed by several minutes to hours. Conversely, lactate falls slowly after perfusion is restored because accumulated lactate must be cleared. This lag means that early in resuscitation, a stable or slightly rising lactate does not necessarily indicate treatment failure, and early in recovery, a persistently elevated lactate does not necessarily indicate ongoing hypoxia. ## Serial Measurement and Clearance Serial lactate measurement is the core monitoring strategy. The value lies in the trajectory, not the absolute number. A patient whose lactate falls from 6 mmol/L to 3 mmol/L over 4 hours is improving, even though the current value remains elevated. A patient whose lactate rises from 2 mmol/L to 4 mmol/L is deteriorating, even though the absolute values are lower than in the first example. Lactate clearance is calculated as the percentage decrease from the initial value. For example, a fall from 4 mmol/L to 2 mmol/L represents 50% clearance. Faster clearance is associated with better outcomes across human critical care literature, and the same physiologic logic applies to dogs and cats. Measurement intervals of 2 to 4 hours during active resuscitation are practical, with longer intervals once the patient stabilizes. Sampling site should remain consistent, as venous, arterial, and capillary samples differ slightly. ## Limitations and Confounders Lactate is not specific for hypoperfusion. Seizures, vigorous muscle activity, and catecholamine administration can elevate lactate through increased production. Hypothermia reduces both production and clearance, complicating interpretation. In small patients, sample volume and handling matter, glycolysis continues in vitro if samples are not processed promptly, falsely elevating results. Point-of-care analyzers should be validated against laboratory methods, and quality assurance guidance from the American Society for Veterinary Clinical Pathology emphasizes method validation and reference interval verification. The evidence base for lactate-guided resuscitation in dogs and cats is less robust than in human medicine. Most veterinary data derive from observational studies and extrapolation from human trials. Species differences in metabolism and disease presentation exist, and clinicians should interpret lactate trends within the full clinical context instead of as an isolated decision rule. ## Sampling Technique and Analytical Considerations Arterial sampling remains the reference method for lactate measurement because it reflects global perfusion most directly. Venous samples are acceptable when arterial access is impractical, but the clinician must interpret venous values with the understanding that they may run slightly higher than arterial values during low-flow states. Capillary samples are the least reliable and should be reserved for situations where neither arterial nor venous access exists. Point-of-care analyzers and benchtop blood gas machines produce comparable results when properly calibrated, but the same instrument should be used for serial measurements whenever possible. Different analyzers use different enzymatic methods and reference intervals, so switching platforms mid-monitoring can create artifactual trends. The [American Society for Veterinary Clinical Pathology quality assurance guidelines](https://www.asvcp.org/page/QALS_Guidelines) emphasize that method validation and consistent quality control are prerequisites for interpreting serial results. Sample handling matters. Lactate is stable in whole blood for approximately 30 minutes at room temperature and longer when the sample is kept on ice. Glycolysis continues in the tube after collection, which can falsely elevate lactate if processing is delayed. Fluoride-oxalate tubes arrest glycolysis and extend stability, but most veterinary emergency settings process samples immediately, making this less relevant in practice. ## Interpreting the First Recheck The initial lactate value establishes the baseline, but the first recheck, typically 2 to 4 hours after initiating therapy, provides the earliest actionable information. A single elevated value cannot distinguish between a patient who is responding to resuscitation and one who is not. Serial measurement answers that question. The target is a lactate clearance of at least 10% per hour during the first 6 hours of resuscitation, with a goal of normalization, usually below 2 mmol/L, within 12 to 24 hours depending on the underlying disease. These thresholds are adapted from human critical care literature and have not been validated to the same degree in dogs and cats. The [MSD Veterinary Manual](https://www.msdvetmanual.com/) cautions that extrapolation of human-derived targets to veterinary patients requires adjustment for species differences in metabolism and disease spectrum. A falling lactate with improving perfusion parameters supports continued therapy. A static or rising lactate despite apparent hemodynamic stabilization should prompt a search for ongoing hypoperfusion, a source of lactate production that has not been addressed, or a non-hypoxic cause of hyperlactatemia. ## The Problem of Occult Hypoperfusion Traditional resuscitation endpoints can be misleading. Normalization of heart rate, blood pressure, and mucous membrane color does not guarantee restoration of tissue perfusion. In a clinical observational study of dogs with shock, [decreased central venous oxygen saturation was documented in a substantial proportion of patients resuscitated to normal traditional perfusion parameters](https://pubmed.ncbi.nlm.nih.gov/24739032/), and hyperlactatemia was commonly recorded in the same population. This occult hypoperfusion is precisely the scenario where serial lactate measurement adds value beyond the physical examination. When blood pressure and heart rate have normalized but lactate remains elevated, the clinician should consider whether the resuscitation is complete. Options include additional fluid therapy guided by dynamic parameters such as pulse pressure variation or passive leg raise response, vasopressor support if fluid responsiveness has been excluded, and inotropic support if myocardial dysfunction is suspected. The [monitoring principles described for critically ill equine patients](https://pubmed.ncbi.nlm.nih.gov/15062457/) apply equally to small animal practice: trends over time are more informative than isolated values, and monitoring tools are useful for detecting occult derangements and determining the effects of therapy. ## Lactate Clearance as a Resuscitation Target Lactate clearance can serve as both a monitoring parameter and a therapeutic target. The distinction matters. Using clearance as a target means the clinician continues or adjusts therapy until the clearance rate is achieved, instead of simply observing what happens to the lactate concentration. | Resuscitation Phase | Recheck Interval | Target | Action if Target Not Met | |---|---|---|---| | Initial stabilization (0 to 6 hours) | Every 2 hours | Clearance ≥ 10% per hour | Reassess volume status, consider vasopressors or inotropes, search for source control failure | | Ongoing resuscitation (6 to 24 hours) | Every 4 to 6 hours | Progressive decline toward normal | Re-evaluate for ongoing ischemia, non-hypoxic lactate sources, or inadequate oxygen delivery | | Post-resuscitation (24 to 48 hours) | Every 8 to 12 hours | Normalization or plateau near reference interval | Investigate persistent elevation for occult infection, hypoperfusion, or hepatic dysfunction | The recheck intervals in this table are pragmatic recommendations based on the kinetics of lactate clearance and the time course of resuscitation. They should be adjusted to the individual patient. A cat with severe septic peritonitis may require more frequent monitoring during the initial phase than a dog with uncomplicated hypovolemic shock from acute blood loss. ## Species Differences in Lactate Kinetics Cats present a particular interpretive challenge. Feline lactate concentrations are often lower than canine values for comparable disease severity, and cats with shock may have lactate values that fall within or near the reference interval despite obvious hypoperfusion. This does not mean the cat is perfusing adequately. It means the clinician cannot rely on lactate alone to exclude tissue hypoxia in this species. The [MSD Veterinary Manual](https://www.msdvetmanual.com/) notes that cats with hepatic lipidosis and other metabolic diseases may have elevated lactate from non-hypoxic causes, further complicating interpretation. In cats, a normal lactate does not rule out shock, and an elevated lactate does not always indicate hypoperfusion. Serial trends are still useful, but the clinician should place greater weight on clinical perfusion parameters and central venous oxygen saturation when available. Dogs are more predictable in their lactate response to hypoperfusion, but breed and body condition influence baseline values. Sighthounds and other breeds with high muscle mass may have higher resting lactate concentrations. Obese patients may clear lactate more slowly due to reduced hepatic perfusion relative to metabolic demand. ## Documenting the Monitoring Protocol Serial lactate measurements should be recorded on a flowsheet that includes the time of sampling, the sampling site, the analyzer used, and concurrent perfusion parameters. This documentation serves three purposes. It allows the clinician to visualize the trend at a glance. It provides a record of therapeutic decisions and their rationale. It creates data that can be reviewed if the patient deteriorates or if a second opinion is sought. The flowsheet should include heart rate, respiratory rate, blood pressure, mucous membrane color, capillary refill time, urine output, and central venous oxygen saturation when available. Lactate values are most meaningful when interpreted in the context of these other parameters. A lactate that is falling while blood pressure is also falling may indicate that the patient is being under-resuscitated. A lactate that is rising while blood pressure is normal may indicate an unrecognized source of lactate production or a non-hypoxic cause. The [AVMA practice resources](https://www.avma.org/resources-tools) emphasize that medical records should support continuity of care and defensible clinical decision-making. A structured monitoring protocol with clear documentation of lactate trends and the therapeutic response to those trends satisfies both objectives. ## When to Stop Monitoring Serial lactate monitoring should continue until the lactate has normalized or plateaued at a stable value for at least 12 hours in a patient whose clinical condition is improving. Stopping earlier risks missing a delayed deterioration. Continuing longer than necessary consumes resources and adds little information. Discontinuation criteria include a lactate within the reference interval for the species and analyzer, stable or improving perfusion parameters, and no ongoing source of lactate production. If the lactate plateaus above the reference interval in a patient who is otherwise stable, the clinician should investigate non-hypoxic causes such as hepatic dysfunction, thiamine deficiency, or drug effects before attributing the elevation to resolved hypoperfusion. The decision to stop monitoring is as important as the decision to start. It should be made deliberately, documented clearly, and revisited if the patient's condition changes. ## Recognized Complications and Failure Modes Serial lactate monitoring fails clinically when the measurement loses its link to perfusion status. The most common failure is treating the number instead of the patient. A falling lactate in a dog with worsening tachycardia, prolonged capillary refill time, and falling blood pressure does not indicate recovery, it indicates that lactate production has declined for reasons unrelated to improved oxygen delivery, such as reduced muscle perfusion or exhausted glycolytic substrate. The converse error is equally dangerous: a rising lactate in a patient with normal vital parameters may reflect ongoing occult hypoperfusion instead of a new complication. [Decreased central venous oxygen saturation despite normalization of heart rate and blood pressure post shock resuscitation in sick dogs](https://pubmed.ncbi.nlm.nih.gov/24739032/) demonstrated that a substantial proportion of dogs resuscitated to normal traditional perfusion parameters still had low central venous oxygen saturation, and hyperlactatemia was commonly recorded in the same population. Lactate trends must therefore be interpreted within a composite perfusion assessment, not as a standalone vital sign. Another failure mode is sampling error masked by analytical precision. A single elevated value obtained from a struggling cat or from a vein distal to a tourniquet can trigger unnecessary intervention. Conversely, a falsely low value from a sample that clotted or was delayed before analysis can create false reassurance. The discriminating check is repeat sampling from a consistent site with immediate analysis, paired with the clinical trajectory. ## Common Errors and Corrective Actions Less experienced clinicians frequently make three errors. First, they measure lactate once and treat the absolute value as diagnostic. The correct action is to establish a baseline and recheck at fixed intervals, because the trend over time carries more prognostic information than any single reading. Second, they fail to account for the time course of clearance. A lactate that has fallen by 20% at two hours may still be rising toward a dangerous peak if the initial value was very high, the rate of change matters more than the proportional change from an arbitrary starting point. Third, they interpret a normal lactate as proof of adequate perfusion. [Monitoring the critically ill equine patient](https://pubmed.ncbi.nlm.nih.gov/15062457/) notes that physiologic parameters such as lactate are useful to detect occult derangements including tissue hypoxia, but also emphasizes that attention to trends over time is what drives therapeutic adjustment. A single normal value cannot exclude regional hypoperfusion, particularly in the splanchnic bed. The corrective framework is simple: define the recheck interval before the first result returns, plot the values on a flow sheet, and document the perfusion parameters that accompany each measurement. If the lactate is falling but perfusion is not improving, reassess the diagnosis. If perfusion is improving but lactate is not falling, consider ongoing ischemia, reduced clearance from hepatic dysfunction, or a Type B contributor. ## Limitations of the Current Evidence The veterinary evidence base for lactate-guided resuscitation remains largely extrapolated from human medicine and from experimental models. [An ovine septic shock model of live bacterial infusion](https://pubmed.ncbi.nlm.nih.gov/39467921/) illustrates the complexity of reproducing clinical sepsis in large animals, and the translational gap between such models and spontaneous disease in dogs and cats is substantial. No prospective randomised trial has established a specific lactate clearance threshold that should trigger or terminate fluid resuscitation in dogs or cats. Expert opinion differs on whether a fixed clearance percentage, an absolute target value, or a time-to-normalization approach is superior. The [MSD Veterinary Manual](https://www.msdvetmanual.com/) presents lactate as one component of perfusion assessment instead of a standalone target, and this reflects the prevailing clinical view. Species differences compound the uncertainty. Cats frequently have elevated lactate from stress, restraint, or sampling difficulty, and their clearance kinetics may differ from dogs. The published reference intervals used by most laboratories were derived from healthy populations and may not apply to critically ill patients with altered acid-base status, hepatic function, or body temperature. [American Society for Veterinary Clinical Pathology guidelines](https://www.asvcp.org/page/QALS_Guidelines) emphasize that reference intervals must be validated for the instrument and population in use, a point often overlooked in emergency settings. ## Escalation and Referral Referral to a specialist or a 24-hour critical care facility is warranted when serial lactate measurements show a rising trend despite resuscitation, when lactate fails to decline within the expected timeframe, or when the patient requires repeated reassessment at intervals that the primary practice cannot sustain. Specialist consultation is also appropriate when the cause of hyperlactatemia is unclear after initial stabilization, particularly when hepatic dysfunction, neoplasia, or a toxic exposure is suspected. Laboratory involvement may be needed when point-of-care and central laboratory results disagree, when the analyzer fails internal quality control, or when the clinical picture contradicts the laboratory value. [American Society for Veterinary Clinical Pathology guidelines](https://www.asvcp.org/page/QALS_Guidelines) provide the framework for method validation and quality assurance that should govern these decisions. Regulatory reporting is rarely triggered by lactate values themselves, but the underlying condition may be reportable. Where infectious or notifiable disease is suspected, the [WOAH terrestrial animal health standards](https://www.woah.org/en/what-we-do/standards/codes-and-manuals/terrestrial-code-online-access/) and local veterinary authorities define the obligations. | Observation | Likely cause | Discriminating check | |---|---|---| | Lactate falling, perfusion worsening | Lactate no longer reflects oxygen debt | Reassess heart rate, blood pressure, mentation, urine output | | Lactate rising, perfusion normal | Occult hypoperfusion or Type B cause | Central venous oxygen saturation if available, recheck in 30 to 60 minutes | | Single high value in a stressed cat | Sampling artefact or stress hyperlactatemia | Repeat from a fresh venipuncture before intervening | | Point-of-care and laboratory values disagree | Analyzer calibration or sample handling error | Run a control sample, check collection site and time to analysis | | Lactate plateau above reference interval | Ongoing ischemia, reduced clearance, or mixed cause | Assess hepatic function, perfusion, and source control | ## Frequently Asked Questions ### How Should I Prioritize Lactate Monitoring When Point-of-Care Equipment Is Unavailable? When a lactate meter or blood gas analyzer is not available, rely on serial physical examination findings and other perfusion markers. Mucous membrane color, capillary refill time, heart rate, pulse quality, and blood pressure trends provide indirect evidence of perfusion. Central venous oxygen saturation, when measurable, can reveal occult hypoperfusion even after traditional parameters normalize, as demonstrated in canine shock patients. If you can obtain samples but must send them to an outside laboratory, request chilled, rapidly processed samples and interpret single values cautiously. Document the limitation explicitly in the medical record so subsequent clinicians understand that clearance calculations were not possible and adjust their monitoring expectations accordingly. ### What Is the Minimum Number of Lactate Measurements Needed to Guide Resuscitation? A single measurement establishes a baseline but cannot distinguish improving from deteriorating perfusion. At least two measurements are required to calculate clearance, and three or more are typically needed to identify a trend. The first recheck should occur after a defined therapeutic intervention, such as a fluid bolus or vasopressor adjustment, with timing guided by the suspected pathophysiology. Subsequent measurements should follow a scheduled interval instead of being performed only when the patient appears worse. Serial trends over time provide more clinically useful information than isolated values, because monitoring techniques are most informative when attention is paid to alterations over time. If resources are limited, prioritize the second measurement over additional baseline tests. ### How Do I Interpret a Rising Lactate When the Patient's Perfusion Looks Clinically Improved? This dissociation is a recognized phenomenon. Traditional perfusion parameters can normalize while tissue hypoxia persists, and a significant proportion of critically ill dogs show decreased central venous oxygen saturation despite normal heart rate and blood pressure after resuscitation. A rising lactate in this context suggests ongoing dysoxia, inadequate oxygen delivery, or developing complications such as ischemic bowel or sepsis progression. Do not dismiss the value because the patient appears stable. Reassess oxygen delivery variables, consider whether sedation or analgesia is masking deterioration, and evaluate for new sources of lactate production. Escalate monitoring intensity and revisit the resuscitation plan instead of extending the interval between measurements. ### How Should I Discuss Serial Lactate Monitoring Costs With a Client? Frame lactate monitoring as a diagnostic tool that informs treatment decisions and may reduce overall costs by guiding more efficient resuscitation. Explain that each measurement provides information about whether the current treatment is working, and that repeated measurements can help avoid prolonged intensive care or detect deterioration earlier. Offer a transparent estimate of the number of measurements typically needed in the first 24 hours, but acknowledge that this depends on response to therapy. For clients with financial constraints, propose a reduced monitoring schedule that preserves the most informative time points, such as baseline and post-intervention recheck. Document the agreed plan and any limitations in the medical record. ### Does the Monitoring Approach Differ for Cats Compared With Dogs? Yes, practical differences exist. Feline patients are smaller, making repeated venous sampling more challenging, and they are more prone to stress-related handling complications that can confound perfusion assessment. Cats may require sedation for sampling, which itself can affect lactate values and cardiovascular parameters. Sample volume requirements are more restrictive, so point-of-care devices requiring minimal blood are advantageous. The underlying disease spectrum differs, with cats more frequently presenting with conditions such as hepatic lipidosis or cholangitis that can influence lactate metabolism through non-hypoxic mechanisms. Apply the same interpretive framework but adjust sampling frequency and handling protocols to minimize stress and iatrogenic variation. ### How Should I Document Lactate Trends in the Medical Record? Record each value with the exact sampling time, site, analyzer used, and any relevant concurrent events such as fluid boluses, vasopressor initiation, or blood product administration. Calculate and document clearance percentage at each recheck using a consistent formula. Note the clinical context at the time of sampling, including temperature, blood pressure, and sedation status, because these factors influence interpretation. Flag values that trigger a change in therapy and describe the clinical reasoning. This documentation supports continuity of care and provides a defensible record of clinical decision-making. Reference ranges and method validation details should follow laboratory quality assurance standards, and any analyzer-specific reference intervals should be noted in the record. ## Related Clinical & Scientific Guides * [Peripheral Blood Smear Evaluation: A Step-by-Step Guide](/knowledge/veterinary-medicine/clinical-pathology/peripheral-blood-smear-evaluation-guide) * [Reticulocyte Counts in Veterinary Medicine: Clinical Utility and Interpretation](/knowledge/veterinary-medicine/clinical-pathology/reticulocyte-counts-veterinary-medicine) * [Cerebrospinal Fluid Analysis in Veterinary Neurology: Collection and Interpretation](/knowledge/veterinary-medicine/clinical-pathology/cerebrospinal-fluid-analysis-veterinary) ## References and Further Reading - [Monitoring the critically ill equine patient.](https://pubmed.ncbi.nlm.nih.gov/15062457/). 2004. - [[Biofilters and biosensors].](https://pubmed.ncbi.nlm.nih.gov/18034417/). 2007. - [Decreased central venous oxygen saturation despite normalization of heart rate and blood pressure post shock resuscitation in sick dogs.](https://pubmed.ncbi.nlm.nih.gov/24739032/). 2014. - [Non-invasive monitoring of microcirculation dynamics in hypovolemic shock: a novel application of diffuse correlation spectroscopy.](https://pubmed.ncbi.nlm.nih.gov/40450616/). 2025. - [Effect of inhaled hydrogen sulfide on metabolic responses in anesthetized, paralyzed, and mechanically ventilated piglets.](https://pubmed.ncbi.nlm.nih.gov/18477923/). 2008. - [An ovine septic shock model of live bacterial infusion.](https://pubmed.ncbi.nlm.nih.gov/39467921/). 2024. - [American Society for Veterinary Clinical Pathology Guidelines](https://www.asvcp.org/page/QALS_Guidelines). American Society for Veterinary Clinical Pathology. - [MSD Veterinary Manual, Professional Edition](https://www.msdvetmanual.com/). MSD Veterinary Manual. - [American Veterinary Medical Association Practice Resources](https://www.avma.org/resources-tools). American Veterinary Medical Association. ## Related Articles - [Monitoring Electrolyte and Acid-Base Status in Critically Ill Patients](/knowledge/veterinary-medicine/clinical-pathology/monitoring-electrolyte-acid-base-status-critically-ill-patients) - [Serial Coagulation Monitoring in Veterinary Patients: Indications and Interpretation](/knowledge/veterinary-medicine/clinical-pathology/serial-coagulation-monitoring-veterinary-patients-indications-interpretation) - [Monitoring Hematologic Recovery After Chemotherapy in Veterinary Patients](/knowledge/veterinary-medicine/clinical-pathology/monitoring-hematologic-recovery-after-chemotherapy-veterinary-patients) - [Monitoring Serum Bile Acids for Hepatobiliary Disease Management](/knowledge/veterinary-medicine/clinical-pathology/monitoring-serum-bile-acids-hepatobiliary-disease-management) - [Monitoring Serum Protein Electrophoresis in Chronic Inflammatory Diseases](/knowledge/veterinary-medicine/clinical-pathology/monitoring-serum-protein-electrophoresis-chronic-inflammatory-diseases) > This article is educational professional reference material for veterinary audiences. It is not a substitute for veterinary diagnosis, individual clinical judgment, current product labeling, or applicable regulatory requirements.